267 related articles for article (PubMed ID: 15297427)
1. Pharmacokinetics and tissue disposition of indole-3-carbinol and its acid condensation products after oral administration to mice.
Anderton MJ; Manson MM; Verschoyle RD; Gescher A; Lamb JH; Farmer PB; Steward WP; Williams ML
Clin Cancer Res; 2004 Aug; 10(15):5233-41. PubMed ID: 15297427
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of tumor modulation by indole-3-carbinol. Disposition and excretion in male Fischer 344 rats.
Stresser DM; Williams DE; Griffin DA; Bailey GS
Drug Metab Dispos; 1995 Sep; 23(9):965-75. PubMed ID: 8565787
[TBL] [Abstract][Full Text] [Related]
3. Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane.
Reed GA; Arneson DW; Putnam WC; Smith HJ; Gray JC; Sullivan DK; Mayo MS; Crowell JA; Hurwitz A
Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2477-81. PubMed ID: 17164373
[TBL] [Abstract][Full Text] [Related]
4. Physiological modeling of formulated and crystalline 3,3'-diindolylmethane pharmacokinetics following oral administration in mice.
Anderton MJ; Manson MM; Verschoyle R; Gescher A; Steward WP; Williams ML; Mager DE
Drug Metab Dispos; 2004 Jun; 32(6):632-8. PubMed ID: 15155555
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of an HPLC method for the simultaneous quantification of indole-3-carbinol acetate, indole-3-carbinol, and 3,3'-diindolylmethane in mouse plasma, liver, and kidney tissues.
Moussata J; Wang Z; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 May; 958():1-9. PubMed ID: 24686233
[TBL] [Abstract][Full Text] [Related]
6. Indole-3-Carbinol (I3C) and its Major Derivatives: Their Pharmacokinetics and Important Roles in Hepatic Protection.
Wang SQ; Cheng LS; Liu Y; Wang JY; Jiang W
Curr Drug Metab; 2016; 17(4):401-9. PubMed ID: 26651978
[TBL] [Abstract][Full Text] [Related]
7. 3,3'-diindolylmethane, a major condensation product of indole-3-carbinol, is a potent estrogen in the rainbow trout.
Shilling AD; Carlson DB; Katchamart S; Williams DE
Toxicol Appl Pharmacol; 2001 Feb; 170(3):191-200. PubMed ID: 11162784
[TBL] [Abstract][Full Text] [Related]
8. The natural chemopreventive compound indole-3-carbinol: state of the science.
Rogan EG
In Vivo; 2006; 20(2):221-8. PubMed ID: 16634522
[TBL] [Abstract][Full Text] [Related]
9. Liquid chromatographic assay for the simultaneous determination of indole-3-carbinol and its acid condensation products in plasma.
Anderton MJ; Jukes R; Lamb JH; Manson MM; Gescher A; Steward WP; Williams ML
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Apr; 787(2):281-91. PubMed ID: 12650751
[TBL] [Abstract][Full Text] [Related]
10. Review. Indole-3-carbinol as a chemoprotective agent in breast and prostate cancer.
Bradlow HL
In Vivo; 2008; 22(4):441-5. PubMed ID: 18712169
[TBL] [Abstract][Full Text] [Related]
11. In vivo disposition of the natural anti-carcinogen indole-3-carbinol after po administration to rainbow trout.
Dashwood RH; Uyetake L; Fong AT; Hendricks JD; Bailey GS
Food Chem Toxicol; 1989 Jun; 27(6):385-92. PubMed ID: 2792968
[TBL] [Abstract][Full Text] [Related]
12. Anticarcinogenic activity of indole-3-carbinol acid products: ultrasensitive bioassay by trout embryo microinjection.
Dashwood RH; Fong AT; Arbogast DN; Bjeldanes LF; Hendricks JD; Bailey GS
Cancer Res; 1994 Jul; 54(13):3617-9. PubMed ID: 8012989
[TBL] [Abstract][Full Text] [Related]
13. Concurrent flavin-containing monooxygenase down-regulation and cytochrome P-450 induction by dietary indoles in rat: implications for drug-drug interaction.
Katchamart S; Stresser DM; Dehal SS; Kupfer D; Williams DE
Drug Metab Dispos; 2000 Aug; 28(8):930-6. PubMed ID: 10901703
[TBL] [Abstract][Full Text] [Related]
14. Intranasal delivery of liposomal indole-3-carbinol improves its pulmonary bioavailability.
Song JM; Kirtane AR; Upadhyaya P; Qian X; Balbo S; Teferi F; Panyam J; Kassie F
Int J Pharm; 2014 Dec; 477(1-2):96-101. PubMed ID: 25311179
[TBL] [Abstract][Full Text] [Related]
15. 3,3'-Diindolylmethane, a cruciferous vegetable derived synthetic anti-proliferative compound in thyroid disease.
Tadi K; Chang Y; Ashok BT; Chen Y; Moscatello A; Schaefer SD; Schantz SP; Policastro AJ; Geliebter J; Tiwari RK
Biochem Biophys Res Commun; 2005 Nov; 337(3):1019-25. PubMed ID: 16219298
[TBL] [Abstract][Full Text] [Related]
16. Fate of indole-3-carbinol in cultured human breast tumor cells.
Staub RE; Feng C; Onisko B; Bailey GS; Firestone GL; Bjeldanes LF
Chem Res Toxicol; 2002 Feb; 15(2):101-9. PubMed ID: 11849035
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of chronic dietary exposure to indole-3-carbinol and absorption-enhanced 3,3'-diindolylmethane in sprague-dawley rats.
Leibelt DA; Hedstrom OR; Fischer KA; Pereira CB; Williams DE
Toxicol Sci; 2003 Jul; 74(1):10-21. PubMed ID: 12730619
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha as a target for indole-3-carbinol.
Wang TT; Milner MJ; Milner JA; Kim YS
J Nutr Biochem; 2006 Oct; 17(10):659-64. PubMed ID: 16488130
[TBL] [Abstract][Full Text] [Related]
19. Reversal of multidrug resistance in vivo by dietary administration of the phytochemical indole-3-carbinol.
Christensen JG; LeBlanc GA
Cancer Res; 1996 Feb; 56(3):574-81. PubMed ID: 8564974
[TBL] [Abstract][Full Text] [Related]
20. Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments.
Bradlow HL; Zeligs MA
In Vivo; 2010; 24(4):387-91. PubMed ID: 20668304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
